4D Molecular Therapeutics
FDMT
trading on NASDAQ
since 2020
$6.40
(Δ 42.00%)
+$1.89 since open
4D Molecular Therapeutics focuses on gene therapy and personalized medicine, developing treatments that target the genetic causes of diseases through innovative engineering for precision and long-term therapeutic impact.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.28 | $6.69 | $4.99 | $208.46M | 31.67M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.86 | n/a | 25482.99 | -383007.14% | -342657.14% | 0% |